[Glecaprevir/pibrentasvir in combination with ribavirin as salvage therapy in chronic hepatitis C]. [PDF]
Sánchez Suárez MM +2 more
europepmc +1 more source
Velpatasvir y sofosbuvir: ¿Por qué utilizar un fármaco nuevo si los antiguos funcionan bien? [PDF]
Flamm SL.
europepmc +1 more source
Dried blood spot as alternative specimen for molecular epidemiology studies among HCV/HIV coinfected patients. [PDF]
Flores G +9 more
europepmc +1 more source
Position Statement on the Use of Antiplatelet Agents and Anticoagulants in Patients Infected with the New Coronavirus (COVID-19) - 2020. [PDF]
Soeiro AM +7 more
europepmc +1 more source
Safety and Efficacy of Direct Antiviral Agents for Hepatitis C in Patients with Malignancies Other Than Liver Cancer: A Case Series. [PDF]
Patauner F +7 more
europepmc +1 more source
[Characterization of tofacitinib use as COVID-19 therapy]. [PDF]
Toribio Polanco FJ +6 more
europepmc +1 more source
Insuficiencia hepática aguda secundaria a fiebre amarilla: un escenario complejo. [PDF]
Song ATW, D'Albuquerque YLAC.
europepmc +1 more source
Control of occult hepatitis B virus infection. [PDF]
Lalana Garcés M +14 more
europepmc +1 more source
Conocimientos básicos sobre enfermedades víricas emergentes: apuntes para atención primaria (parte 2). [PDF]
Alonso Saratxaga E, Pérez Esquerdo MR.
europepmc +1 more source
[Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)]. [PDF]
Díaz E +8 more
europepmc +1 more source

